Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Meridian Bioscience Inc's Business Segments
Meridian Bioscience Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2023
Reportable Segments
2
Largest Segment
Diagnostics
Total Revenue
$ 57
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2023
- Diagnostics69.2%
- Life Science30.8%
Revenue by Reportable Segment - Q1 FY2023
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Diagnostics | $ 39 | 69.2% |
| Life Science | $ 18 | 30.8% |
Revenue by Product & Service Category - Q1 FY2023
- Non Molecular Assays61.3%
- Gastrointestinal Assays37.4%
- Immunological Reagents17.5%
- Molecular Reagents13.3%
- Other Diagnostics11.9%
- Respiratory Illness Assays11.8%
- Blood Chemistry Assays8.1%
- Molecular Assays7.9%
Revenue by Product & Service Category - Q1 FY2023
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Non Molecular Assays | $ 35 | 61.3% |
| Gastrointestinal Assays | $ 21 | 37.4% |
| Immunological Reagents | $ 10 | 17.5% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
5 more categories available
Sign in to unlock the full Meridian Bioscience Inc dataset.
Description of Meridian Bioscience Inc
Meridian Bioscience Inc.
is a US-based company that specializes in the development, manufacturing, and distribution of diagnostic test kits, reagents, and related products for the healthcare industry.
The company's main product lines include gastrointestinal, respiratory, and viral and parasitic infection diagnostic test kits, as well as molecular diagnostic tests.
Meridian Bioscience Inc.
was founded in 1976 and is headquartered in Cincinnati, Ohio.
The company's mission is to improve global human health by providing innovative and high-quality diagnostic solutions.
Meridian Bioscience Inc.
is a publicly traded company, listed on the NASDAQ stock exchange under the ticker symbol VIVO.
The company operates through two main segments: Diagnostics and Life Science.
The Diagnostics segment primarily focuses on the development, manufacturing, and distribution of diagnostic test kits for gastrointestinal, respiratory, and viral and parasitic infection diagnostics.
The Life Science segment focuses on providing molecular diagnostic reagents, including RNA and DNA extraction kits and fluorescent dyes for research and clinical applications.
Meridian Bioscience Inc.
serves customers in more than 70 countries worldwide, including hospitals, reference laboratories, research institutes, and physician offices.
The company has established partnerships with leading healthcare organizations and diagnostic companies to expand its product portfolio and to advance healthcare solutions.
In addition, the company has invested heavily in research and development activities to diversify its product offerings and to stay at the forefront of diagnostic innovation.
Overall, Meridian Bioscience Inc.
has developed a reputation as a trusted supplier of quality diagnostic products and as an innovator in the diagnostic industry.
is a US-based company that specializes in the development, manufacturing, and distribution of diagnostic test kits, reagents, and related products for the healthcare industry.
The company's main product lines include gastrointestinal, respiratory, and viral and parasitic infection diagnostic test kits, as well as molecular diagnostic tests.
Meridian Bioscience Inc.
was founded in 1976 and is headquartered in Cincinnati, Ohio.
The company's mission is to improve global human health by providing innovative and high-quality diagnostic solutions.
Meridian Bioscience Inc.
is a publicly traded company, listed on the NASDAQ stock exchange under the ticker symbol VIVO.
The company operates through two main segments: Diagnostics and Life Science.
The Diagnostics segment primarily focuses on the development, manufacturing, and distribution of diagnostic test kits for gastrointestinal, respiratory, and viral and parasitic infection diagnostics.
The Life Science segment focuses on providing molecular diagnostic reagents, including RNA and DNA extraction kits and fluorescent dyes for research and clinical applications.
Meridian Bioscience Inc.
serves customers in more than 70 countries worldwide, including hospitals, reference laboratories, research institutes, and physician offices.
The company has established partnerships with leading healthcare organizations and diagnostic companies to expand its product portfolio and to advance healthcare solutions.
In addition, the company has invested heavily in research and development activities to diversify its product offerings and to stay at the forefront of diagnostic innovation.
Overall, Meridian Bioscience Inc.
has developed a reputation as a trusted supplier of quality diagnostic products and as an innovator in the diagnostic industry.
Meridian Bioscience Inc. is a globally recognized manufacturer and distributor that offers a comprehensive suite of life science products and services, segmented into three major categories: Diagnostic, Life Sciences, and Blood Typing. Each segment embodies specific offerings that cater to various aspects of medical research, diagnostics, and clinical laboratory testing, ensuring that the company meets diverse needs across global healthcare markets.
1) Diagnostic Segment
The Diagnostic Segment of Meridian Bioscience Inc. is primarily focused on products aimed at the detection and diagnosis of infectious diseases. This segment is crucial for healthcare providers in identifying ailments, guiding treatment options, and controlling disease outbreaks. Key offerings within this segment include:
- Molecular Diagnostic Tests: Meridian specializes in its illumigene line of molecular diagnostic tests, which leverage innovative technologies for rapid and accurate detection of pathogens. The illumigene tests are notably used for identifying Group A Streptococcus, Group B Streptococcus, Clostridium difficile, and Pertussis. These assays are designed for high-volume automated testing but also cater to point-of-care environments, making them versatile for various clinical settings.
- Rapid Tests: The company provides a range of rapid testing kits that allow for quick diagnosis of gastrointestinal infections, respiratory infections, and other infectious diseases. These products are essential for prompt clinical decisions, reducing turnaround times and improving patient outcomes.
- Research Applications: Meridian Biosciences diagnostic products extend to exotic research applications, allowing laboratories to explore less common infections, which are critical for zoonotic disease studies and global health monitoring.
In summary, Meridian’s diagnostic products are vital for the efficient diagnosis and management of infectious diseases, facilitating timely patient care and effective outbreak monitoring.
2) Life Sciences Segment
The Life Sciences Segment of Meridian Bioscience focuses on providing high-quality reagents, antibodies, enzymes, and proteins for research laboratories engaged in various biological and biomedical studies. Key components of this segment include:
- Reagents and Antibodies: The company offers an extensive selection of antibodies, including primary and secondary antibodies, suitable for various applications such as immunohistochemistry, enzyme-linked immunosorbent assay (ELISA), and western blotting.
- DNA and RNA Polymerases: Among the flagship products are the Premier line of DNA polymerases, including Taq polymerase, which is extensively used in polymerase chain reaction (PCR) processes for amplifying DNA. Additionally, RNA polymerases are offered for RNA transcription, contributing to advancements in genetic research.
- Nucleic Acid Extraction Kits: The company provides purification kits and nucleic acid extraction kits that are essential for isolating DNA and RNA from biological samples. These kits are designed to streamline workflows in molecular biology laboratories.
- PCR Amplification Reagents: Meridian’s reagents facilitate the PCR amplification process, a cornerstone technique in molecular biology that enables researchers to exponentially replicate specific DNA sequences for analysis.
In essence, the Life Sciences Segment equips researchers with the tools necessary for groundbreaking studies in molecular biology, genetics, and biochemistry, thus driving innovation and discovery in scientific research.
3) Blood Typing Segment
The Blood Typing Segment of Meridian Bioscience provides essential products for blood group typing and compatibility testing, which are crucial in transfusion medicine and organ transplantation. This segment includes:
- Blood Grouping Reagents: Meridian offers a comprehensive array of reagents used for blood group typing, including antibodies specific to various blood groups such as ABO, Rh, and rare blood types. This is critical for ensuring safe and compatible blood transfusions.
- Cross-Matching Kits: The company provides cross-matching solutions that identify the compatibility between donor and recipient blood samples. This testing minimizes the risk of adverse transfusion reactions.
- Detection Kits: Meridian offers specialized detection kits to identify autoimmune blood group antibodies. These kits are essential for laboratories conducting thorough investigations to ensure safe blood transfusions.
The Blood Typing Segment is indispensable for blood banks, laboratories, and hospitals, ensuring that transfusion practices are safe and effective for patient care.
Conclusion
In conclusion, Meridian Bioscience Inc. stands as a robust player in the life sciences industry, offering a diverse and comprehensive product portfolio across its Diagnostic, Life Sciences, and Blood Typing segments. The company’s commitment to quality and innovation positions it as a trusted provider in crucial areas such as infectious disease diagnostics, life science research, and transfusion medicine. By delivering high-quality products and services, Meridian Bioscience Inc. effectively supports the advancements in healthcare and research globally.
1) Diagnostic Segment
The Diagnostic Segment of Meridian Bioscience Inc. is primarily focused on products aimed at the detection and diagnosis of infectious diseases. This segment is crucial for healthcare providers in identifying ailments, guiding treatment options, and controlling disease outbreaks. Key offerings within this segment include:
- Molecular Diagnostic Tests: Meridian specializes in its illumigene line of molecular diagnostic tests, which leverage innovative technologies for rapid and accurate detection of pathogens. The illumigene tests are notably used for identifying Group A Streptococcus, Group B Streptococcus, Clostridium difficile, and Pertussis. These assays are designed for high-volume automated testing but also cater to point-of-care environments, making them versatile for various clinical settings.
- Rapid Tests: The company provides a range of rapid testing kits that allow for quick diagnosis of gastrointestinal infections, respiratory infections, and other infectious diseases. These products are essential for prompt clinical decisions, reducing turnaround times and improving patient outcomes.
- Research Applications: Meridian Biosciences diagnostic products extend to exotic research applications, allowing laboratories to explore less common infections, which are critical for zoonotic disease studies and global health monitoring.
In summary, Meridian’s diagnostic products are vital for the efficient diagnosis and management of infectious diseases, facilitating timely patient care and effective outbreak monitoring.
2) Life Sciences Segment
The Life Sciences Segment of Meridian Bioscience focuses on providing high-quality reagents, antibodies, enzymes, and proteins for research laboratories engaged in various biological and biomedical studies. Key components of this segment include:
- Reagents and Antibodies: The company offers an extensive selection of antibodies, including primary and secondary antibodies, suitable for various applications such as immunohistochemistry, enzyme-linked immunosorbent assay (ELISA), and western blotting.
- DNA and RNA Polymerases: Among the flagship products are the Premier line of DNA polymerases, including Taq polymerase, which is extensively used in polymerase chain reaction (PCR) processes for amplifying DNA. Additionally, RNA polymerases are offered for RNA transcription, contributing to advancements in genetic research.
- Nucleic Acid Extraction Kits: The company provides purification kits and nucleic acid extraction kits that are essential for isolating DNA and RNA from biological samples. These kits are designed to streamline workflows in molecular biology laboratories.
- PCR Amplification Reagents: Meridian’s reagents facilitate the PCR amplification process, a cornerstone technique in molecular biology that enables researchers to exponentially replicate specific DNA sequences for analysis.
In essence, the Life Sciences Segment equips researchers with the tools necessary for groundbreaking studies in molecular biology, genetics, and biochemistry, thus driving innovation and discovery in scientific research.
3) Blood Typing Segment
The Blood Typing Segment of Meridian Bioscience provides essential products for blood group typing and compatibility testing, which are crucial in transfusion medicine and organ transplantation. This segment includes:
- Blood Grouping Reagents: Meridian offers a comprehensive array of reagents used for blood group typing, including antibodies specific to various blood groups such as ABO, Rh, and rare blood types. This is critical for ensuring safe and compatible blood transfusions.
- Cross-Matching Kits: The company provides cross-matching solutions that identify the compatibility between donor and recipient blood samples. This testing minimizes the risk of adverse transfusion reactions.
- Detection Kits: Meridian offers specialized detection kits to identify autoimmune blood group antibodies. These kits are essential for laboratories conducting thorough investigations to ensure safe blood transfusions.
The Blood Typing Segment is indispensable for blood banks, laboratories, and hospitals, ensuring that transfusion practices are safe and effective for patient care.
Conclusion
In conclusion, Meridian Bioscience Inc. stands as a robust player in the life sciences industry, offering a diverse and comprehensive product portfolio across its Diagnostic, Life Sciences, and Blood Typing segments. The company’s commitment to quality and innovation positions it as a trusted provider in crucial areas such as infectious disease diagnostics, life science research, and transfusion medicine. By delivering high-quality products and services, Meridian Bioscience Inc. effectively supports the advancements in healthcare and research globally.